TrialBMC cancer2023

SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.

J A Crouzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.